244 related articles for article (PubMed ID: 19008080)
1. Current challenges in the diagnosis and management of invasive fungal infections: report from the 15th International Symposium on Infections in the Immunocompromised Host: Thessaloniki, Greece, 22-25 June 2008.
Groll AH; McNeil Grist L
Int J Antimicrob Agents; 2009 Feb; 33(2):101-4. PubMed ID: 19008080
[TBL] [Abstract][Full Text] [Related]
2. Antifungal prophylaxis in lung transplantation.
Neoh CF; Snell G; Levvey B; Morrissey CO; Stewart K; Kong DC
Int J Antimicrob Agents; 2014 Sep; 44(3):194-202. PubMed ID: 25123811
[TBL] [Abstract][Full Text] [Related]
3. Invasive mold infections: recent advances in management approaches.
Chandrasekar P
Leuk Lymphoma; 2009 May; 50(5):703-15. PubMed ID: 19337880
[TBL] [Abstract][Full Text] [Related]
4. Advances and challenges in management of invasive mycoses.
Patterson TF
Lancet; 2005 Sep 17-23; 366(9490):1013-25. PubMed ID: 16168784
[TBL] [Abstract][Full Text] [Related]
5. Fungal infections in leukemia patients: how do we prevent and treat them?
Leventakos K; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2010 Feb; 50(3):405-15. PubMed ID: 20047485
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
7. Managing invasive fungal disease in immunocompromised patients.
Maertens J; Bryan J
Future Microbiol; 2010 Dec; 5(12):1775-9. PubMed ID: 21155660
[TBL] [Abstract][Full Text] [Related]
8. A multidisciplinary approach to managing invasive fungal disease. Introduction and aims.
Donnelly JP
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii3-4. PubMed ID: 24319773
[No Abstract] [Full Text] [Related]
9. Breakthrough invasive fungal infections: Who is at risk?
Jenks JD; Cornely OA; Chen SC; Thompson GR; Hoenigl M
Mycoses; 2020 Oct; 63(10):1021-1032. PubMed ID: 32744334
[TBL] [Abstract][Full Text] [Related]
10. Current challenges in the management of invasive fungal infections.
Lai CC; Tan CK; Huang YT; Shao PL; Hsueh PR
J Infect Chemother; 2008 Apr; 14(2):77-85. PubMed ID: 18622668
[TBL] [Abstract][Full Text] [Related]
11. Management of invasive fungal infections: a role for polyenes.
Chandrasekar P
J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
[TBL] [Abstract][Full Text] [Related]
12. Advances in the management of fungal infections.
Muñoz P; Valerio M; Vena A; Bouza E; Posteraro B; Lass-Flörl C; Sanguinetti M
Mycoses; 2015 Jun; 58 Suppl 2():1. PubMed ID: 26033250
[No Abstract] [Full Text] [Related]
13. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
Singh N
Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
[TBL] [Abstract][Full Text] [Related]
14. Invasive fungal infections in the ICU.
Shoham S; Marwaha S
J Intensive Care Med; 2010; 25(2):78-92. PubMed ID: 19955115
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections in liver transplantation.
Liu X; Ling Z; Li L; Ruan B
Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and management of fungal infections in immunocompromised patients.
Venkatesan P; Perfect JR; Myers SA
Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
Camps IR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the management of opportunistic fungal infections.
Sanchez JL; Noskin GA
Compr Ther; 1996 Nov; 22(11):703-12. PubMed ID: 8978976
[No Abstract] [Full Text] [Related]
19. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study.
Auberger J; Lass-Flörl C; Aigner M; Clausen J; Gastl G; Nachbaur D
J Antimicrob Chemother; 2012 Sep; 67(9):2268-73. PubMed ID: 22653819
[TBL] [Abstract][Full Text] [Related]
20. Fungal infections in immunocompromised patients.
Sganga G
Mycoses; 2011 Dec; 54 Suppl 4():1-3. PubMed ID: 22126521
[No Abstract] [Full Text] [Related]
[Next] [New Search]
